AMSBIO announces addition of mutation cell line controls to its reference standards

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards.

In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD assay development and established diagnostic tests, reference standards for genomic DNA analysis and Immunohistochemistry (IHC) assays are an essential tool. However reliable sources of reference material for rarer genetic profiles remain a constant challenge.

IsoMax™ reference standardshave been accurately engineered to model the genetics of specific patient populations in vitro. These unique new reference standards can be directly incorporated into sample processing workflows for assay optimization, evaluation of sensitivity and specificity as well as monitoring the impact of workflow changes on downstream analysis.

Building on the CellMax™ range of more than 50 well-known cancer cell line FFPE controls, IsoMax™ reference standards provide a renewable source of control material for recognized mutations in cancer markers. Based on CRISPR/Cas9 isogenic cell lines, a wide range of mutations are offered from target genes, including EGFR, KRAS, BRAF, and PIK3CA.

Available in multiple formats, including FFPE blocks, slides, scrolls, and isolate gDNA, IsoMax™ and CellMax™ standards provide an inexhaustible supply of consistent positive and negative controls.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2017, September 28). AMSBIO announces addition of mutation cell line controls to its reference standards. News-Medical. Retrieved on May 25, 2019 from https://www.news-medical.net/news/20170928/AMSBIO-announces-addition-of-mutation-cell-line-controls-to-its-reference-standards.aspx.

  • MLA

    AMS Biotechnology. "AMSBIO announces addition of mutation cell line controls to its reference standards". News-Medical. 25 May 2019. <https://www.news-medical.net/news/20170928/AMSBIO-announces-addition-of-mutation-cell-line-controls-to-its-reference-standards.aspx>.

  • Chicago

    AMS Biotechnology. "AMSBIO announces addition of mutation cell line controls to its reference standards". News-Medical. https://www.news-medical.net/news/20170928/AMSBIO-announces-addition-of-mutation-cell-line-controls-to-its-reference-standards.aspx. (accessed May 25, 2019).

  • Harvard

    AMS Biotechnology. 2017. AMSBIO announces addition of mutation cell line controls to its reference standards. News-Medical, viewed 25 May 2019, https://www.news-medical.net/news/20170928/AMSBIO-announces-addition-of-mutation-cell-line-controls-to-its-reference-standards.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
AMSBIO introduces FDA standard tissue microarrays